Intuniv XR · DIN 02409127 · 3 mg · extended release tablet
Limited Use, Reason for Use code 540 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 540 required
Write on scriptReason for Use code 540 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 540
Reason for Use code 540
For the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 to 17 years who meet the following criteria:
(i) As adjunctive therapy to psychostimulants; OR
(ii) As monotherapy in patients who have significant intolerance to psychostimulants AND who have had an inadequate response to either atomoxetine or other non-stimulant alternative(s).
Coverage limit:
LU Authorization Period: 1 year
Savings card: innoviCares lists Intuniv XR (Ontario list dated 2026-09-10) — pays part of the brand-versus-generic difference after other coverage; free sign-up. (innovicares.ca ↗)
1 brand, same coverage
Intuniv XR · DIN 02409127
Manufacturer: Takeda Canada Inc.; listing date 2020-01-31
Health Canada: Marketed since 2021-09-01 · brand INTUNIV XR · ATC C02AC02 GUANFACINE · form Tablet (extended-release) · route Oral · ingredients GUANFACINE (GUANFACINE HYDROCHLORIDE) 3 MG · company Takeda canada inc · schedule Prescription
Ministry pays: $1.1019 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02409127)
Source record
DIN 02409127: Intuniv XR
Raw flags: sec12=Y, sec3=Y
Item: 240816003; group id 360; item number 0842; lccId 00326; manufacturer id TAK
Source form: ER Tab; strength: 3mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $4.4075; ministry $1.1019
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02409127
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=89385
Interchangeable products
Apo-Guanfacine XR · DIN 02523744 · $1.1019
Jamp Guanfacine XR · DIN 02523574 · $1.1019
Sandoz Guanfacine XR · DIN 02563207 · $1.1019
Shortage status: not checked (no credentials)